NURECA
Back to Cashflow Statement
|
NURECA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-19 Cr | ₹-2.71 Cr | ₹10 Cr | ₹1.40 Cr | ₹35 Cr |
What is the latest Cash Flow from Operating Activities ratio of NURECA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-2.71 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹1.40 Cr |
| Mar2021 | ₹35 Cr |
How is Cash Flow from Operating Activities of NURECA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-2.71 Cr | Negative | |
| Mar2023 | ₹10 Cr | 631.02 | |
| Mar2022 | ₹1.40 Cr | -95.99 | |
| Mar2021 | ₹35 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NURECA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NURECA | ₹222.2 Cr | -2% | -2.2% | -13% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹91,743.6 Cr | 2.1% | 1.6% | NA | Stock Analytics | |
| POLY MEDICURE | ₹16,875.8 Cr | 0.9% | 24.7% | -20.3% | Stock Analytics | |
| LAXMI DENTAL | ₹1,225.9 Cr | -0.6% | -3% | -47.4% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,028.0 Cr | 2.1% | 8.4% | -16.2% | Stock Analytics | |
| PREVEST DENPRO | ₹450.5 Cr | -2.1% | -3.5% | -20.4% | Stock Analytics | |
NURECA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NURECA | -2% |
-2.2% |
-13% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses